Expression of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid

Experimental Eye Research

Volumn 77, Issue 4, 2003, Pages 433-445

  Kim, Sahng Yeon ^a   Mocanu, Carmen ^a   Mcleod, D Scott ^a   Bhutto, Imran A ^a   Merges, Carol ^a   Eid, Mark ^a   Tong, Patrick ^a   Lutty, Gerard A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Choroid; Pigment epithelium derived factor; Retina; Sea fan neovascularization; Sickle cell retinopathy; Vascular endothelial growth factor

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CHOROID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SICKLE CELL; VITREOUS BODY;

EID: 0041883567     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4835(03)00174-X     Document Type: Article

References (53)

1. Adamis A.P., Miller J.W., Bernal M.-T., D'Amico D.J., Folkman J., Yeo T.-K., Yeo K.-T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118:1994;445-450.
2. Aiello L. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthal. Res. 29:1997;354-362.
3. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H., Shah S.T., Pasquale L.R., Thieme H., Iwamoto M.A., Park J.E., Nguyen H.V., Aiello L.M., Ferrara N., King G. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl. J. Med. 331:1994;1480-1487.
4. Alberdi E., Hyde C.C., Becerra S.P. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. Biochemistry. 37:1998;10643-10652.
5. Alberdi E., Weldon J.E., Bacerra S.P. Glycosaminoglycans in human retinoblastoma cells: heparan sulfate, a modulator of the pigment-epithelium-derived factor-receptor interactions. BMC Biochem. 4:2003;1-9.
6. Araki T., Taniwaki T., Becerra S.P., Chader G.J., Schwartz J.P. Pigment epithelium-derived factor (PEDF) differentially protects immature but not mature cerebellar granule cells against apoptotic cell death. J. Neurosci. Res. 53:1998;7-15.
7. Cao J., Kunz Mathews M., McLeod D.S., Merges C., Hjelmeland L.M., Lutty G.A. Angiogenic factors in human proliferative sickle cell retinopathy. Br. J. Ophthalmol. 83:1999;838-846.
8. Chader G.J. PEDF: raising both hopes and questions in controlling angiogenesis. Proc. Nat. Acad. Sci. 98:2001;2122-2124.
9. Condon P.I., Serjeant G.R. Behaviour of untreated proliferative sickle retinopathy. Br. J. Ophthalmol. 64:1980;404-411.
10. Connor T.B., Roberts A.B., Sporn M.B., Danielpour D., Dart L.L., Michels R.G., deBustros S., Enger S., Kato H., Lansing M., Hayashi H., Glaser B.M. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J. Clin. Invest. 83:1989;1661-1666.
11. D'Amore P.A. Mechanisms of retinal and choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 35:1994;3974-3979.
12. Dawson D.W., Volpert O.V., Gillis P., Crawford S.E., Xu H., Benedict W., Bouck N.P. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 285:1999;245-248.
13. Duh E.J., Yang H.S., Suzuma I., Miyagi M., Youngman E., Mori K., Katai M., Yan L., Suzuma K., West K., Davarya S., Tong P., Gehlbach P., Pearlman J., Crabb J.W., Aiello L.P., Campochiaro P.A., Zack D.J. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest. Ophthalmol. Vis. Sci. 43:2002;821-829.
14. Engerman R.L., Pfaffenbach D., Davis M.D. Cell turnover of capillaries. Lab. Invest. 17:1967;738-743.
15. Gao G., Li Y., Gee S., Dudley A., Fant J., Crosson C., Ma J.X. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5. J. Biol. Chem. 277:2002;9492-9497.
16. Gao G., Li Y., Zhang D., Gee S., Crosson C., Ma J. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 489:2001;270-276.
17. Goldberg M.F. Clinical Ophthalmology. Clinical Ophthalmology. 1976;Harper and Row, Hagerstown, MD. pp. 1-44.
18. Hutchings H., Maitre-Boube M., Tombran-Tink J., Plouet J. Pigment epithelium-derived factor exerts opposite effects on endothelial cells of different phenotypes. Biochem. Biophys. Res. Commun. 294:2002;764-769.
19. Jacobson B., Basu P.K., Hasany S.M. Vascular endothelial cell growth inhibitor of normal and pathologic human vitreous. Arch. Opthalmol. 102:1984;1543-1545.
20. Karakousis P.C., John S.K., Behling K.C., Surace E.M., Smith J.E., Hendrickson A., Tang W.X., Bennett J., Milam A.H. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mol. Vis. 7:2001;154-163.
21. King G.L., Suzuma K. Pigment-epithelium-derived factor - a key coordinator of retinal neuronal and vascular functions. N Engl. J. Med. 342:2000;349-351.
22. Kunz Mathews M., McLeod D., Merges C., Cao J., Lutty G. Neutrophils and leukocyte adhesion molecules in sickle cell retinopathy. Br. J. Ophthalmol. 86:2002;684-690.
23. Kunz Mathews M., Merges C., McLeod D.S., Lutty G.A. Vascular endothelial growth factor (VEGF) and vascular permeability changes in human diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 38:1997;2729-2741.
24. Lutty, G.A., 1992. Characterization and purification of an inhibitor of endothelial cell proliferation from normal adult vitreous humour. John Hopkins University.
25. Lutty G.A., Chandler C., Bennett A., Fait C., Patz A. Presence of endothelial cell growth factor activity in normal and diabetic eyes. Curr. Eye Res. 5:1986;9-17.
26. Lutty G.A., McLeod D.S., Merges C., Diggs A., Plouét J. Localization of VEGF in human retina and choroid. Arch. Ophthalmol. 114:1996;971-977.
27. Lutty G.A., Mello R.J., Chandler C., Fait C., Bennett A., Patz A. Regulation of cell growth by vitreous humor. J. Cell Sci. 76:1985;53-65.
28. Lutty G.A., Merges C., McLeod D.S. 5′ nucleotidase and adenosine during retinal vasculogenesis and oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 41:2000;218-229.
29. Lutty G.A., Merges C., Threlkeld A.B., Crone S., McLeod D.S. Heterogeneity in localization of isoforms of TGF-β in human retina, vitreous, and choroid. Invest. Ophthalmol. Vis. Sci. 34:1993;477-487.
30. Lutty G.A., Thompson D.C., Gallup J.Y., Mello R.J., Patz A., Fenselau A. Vitreous: an inhibitor of retinal extract-induced neovascularization. Invest. Ophthalmol. Vis. Sci. 24:1983;52-56.
31. McLeod D.S., Lefer D.J., Merges C., Lutty G.A. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am. J. Pathol. 147:1995;642-653.
32. McLeod D.S., Merges C., Fukushima A., Goldberg M.F., Lutty G.A. Histopathological features of neovascularization in sickle cell retinopathy. Am. J. Ophthalmol. 124:1997;473-487.
33. Meyer C., Notari L., Becerra S.P. Mapping the type 1 collagen binding site on pigment epithelium-derived factor: implications for its antiangiogenic activity. J. Biol. Chem. 2002;. PMID# 12237317.
34. Michaelson I.C. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans. Ophthalmol. Soc. UK. 68:1948;137-180.
35. Mori K., Duh E., Gehlbach P., Ando A., Takahashi K., Pearlman J., Yang H.S., Zack D.J., Ettyreddy D., Brough D.E., Wei L.L., Campochiaro P.A. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J. Cell Physiol. 188:2001;253-263.
36. Mori K., Gehlbach P., Ando A., McVey D., Wei L., Campochiaro P.A. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest. Ophthalmol. Vis. Sci. 43:2002;2428-2434.
37. Mori K., Gehlbach P., Yamamoto S., Duh E., Zack D.J., Li Q., Berns K.I., Raisler B.J., Hauswirth W.W., Campochiaro P.A. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43:2002b;1994-2000.
38. Nagpal K.C., Patrianakos D., Asdourian G.K., Goldberg M.F., Rabb M., Jampol L.M. Spontaneous regression (autoinfarction) of proliferative sickle retinopathy. Am. J. Ophthalmol. 80:1975;885-892.
39. Ogata N., Nishikawa M., Nishimura T., Mitsuma Y., Matsumura M. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Am. J. Ophthalmol. 133:2002a;851-852.
40. Ogata N., Tombran-Tink J., Jo N., Mrazek D., Matsumura M. Upregulation of pigment epithelium-derived factor after laser photocoagulation. Am. J. Ophthalmol. 132:2001;427-429.
41. Ogata N., Tombran-Tink J., Nishikawa M., Nishimura T., Mitsuma Y., Sakamoto T., Matsumura M. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. Am. J. Ophthalmol. 132:2001;378-382.
42. Ogata N., Wada M., Otsuji T., Jo N., Tombran-Tink J., Matsumura M. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43:2002;1168-1175.
43. Ogata N., Wang L., Jo N., Tombran-Tink J., Takahashi K., Mrazek D., Matsumura M. Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury. Curr. Eye Res. 22:2002;245-252.
44. Ohno-Matsui K., Morita I., Tombran-Tink J., Mrazek D., Onodera M., Uetama T., Hayano M., Murota S.I., Mochizuki M. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J. Cell Physiol. 189:2001;323-333.
45. Page C., Rose M., Yacoub M., Pigott R. Antigenic heterogeneity of vascular endothelium. Am. J. Pathol. 141:1992;673-683.
46. Raymond L., Jacobson B. Isolation and identification of stimulatory and inhibitory cell growth factors in bovine vitreous. Exp. Eye Res. 34:1982;267-286.
47. Romayananda N., Goldberg M.F., Green W.R. Histopathology of sickle cell retinopathy. Trans. Am. Acad. Ophthalmol. Otolaryngol. 77:1973;652-676.
48. Spranger J., Osterhoff M., Reimann M., Mohlig M., Ristow M., Francis M.K., Cristofalo V., Hammes H.P., Smith G., Boulton M., Pfeiffer A.F. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes. 50:2001;2641-2645.
49. Stellmach V., Crawford S.E., Zhou W., Bouck N. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc. Nat. Acad. Sci. 98:2001;2593-2597.
50. Taniwaki T., Hirashima N., Becerra S.P., Chader G.J., Etcheberrigaray R., Schwartz J.P. Pigement epithelium-derived factor protects cultured cerebellar granule cells against glutamate-induced toxicity. J. Neurochem. 68:1997;26-32.
51. Taomoto M., McLeod D.S., Merges C., Lutty G.A. Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 41:2000;230-243.
52. Tombran-Tink J., Chader G.J., Johnson L.V. A pigment epithelium-derived factor with potent neuronal differentiative activity. Exp. Eye Res. 53:1991;411-414.
53. Yasui N., Mori T., Morito O., Matsushita O., Kourai H., Nagata K., Koide T. Dual-site recognition of different extracellular matrix components by anti-angiogenic/neurotrophic serpin, PEDF. Biochemistry. 42:2003;3160-3167.